Going from a medium-dose inhaled corticosteroid to a biologic for asthma led to significant decreases in exacerbations, ...

Extrafine single-inhaler triple therapy with BDP/FF/GB is effective for improving health-related quality of life and lung function in COPD.

Please provide your email address to receive an email when new articles are posted on . Exacerbation risk factors in this population included GERD, chronic bronchitis, high symptom burden and ...

A recent study explored exacerbation history to determine what it revealed about prognosis. The findings suggested that exacerbation severity history was predictive of future exacerbation status.

A metabolomics-based score using sphingolipid and steroid levels predicts the risk for asthma exacerbations and may help ...

Investigators of a 3-year observational study identified independent risk factors for exacerbations related to chronic obstructive pulmonary disease (COPD) and successfully developed a novel risk ...

Findings showed that for individuals with asthma, the significant immunological adaptations typically induced by pregnancy ...

Clinical guidelines recommend use of exacerbation history in choosing therapies to predict the risk for chronic obstructive pulmonary disease exacerbations, but an analysis of data from three ...

According to a recent study, patients with an exacerbation of chronic obstructive pulmonary disease (COPD) have greater risks of both subsequent exacerbations and mortality. The odds of subsequent ...

The SPIROMICS study found considerable year-to-year heterogeneity in acute chronic obstructive pulmonary disease (COPD) exacerbation patterns over 3 years of follow-up. Similarly, a Danish nationwide ...

Acute exacerbations adversely affect patients with chronic obstructive pulmonary disease (COPD). Macrolide antibiotics benefit patients with a variety of inflammatory airway diseases. We performed a ...